main content start

Curtas de vídeo

Mais popular

Mais popular

Popular in Sem nome
  • Câncer de próstata3m 41s

    Whole genome sequencing in clinical practice

    Whole Genome Sequencing (Short)
    Whole Genome Sequencing is new tool for precision medicine in metastatic castration
    precision medicine prostate cancer whole genome sequencing
  • Oncospecials2m 41s

    Low Dose Dasatinib Ready For Clinical Practice

    Several studies carried out by institutions of repute have shown that Dasatinib 50 mg is as effective as 100 mg with less side effects.
    low dose dasatinib dasatinib 50mg
  • Mieloma múltiplo3m 11s

    Tips on using Pomalidomide Based Regimens in Multiple Myeloma

    For relapsed and refractory multiple myeloma, use of pomalidomide often in combination with dexamethasone or other agents is recommended in patients who have failed at least two prior treatments, including lenalidomide and a proteasome inhibitor.
    clinical practice tips improved patient outcomes rrmm management pomalidomide
  • Oncology3m 36s

    Tissue Agnostic Treatment options in Solid Tumors

    Tissue-agnostic treatment based on shared genetic aberrations have provided a new direction in cancer treatment. Emerging clinical evidence indicates that many molecular aberrations can be common across tumor types with different site of origin.
    personalized medicine precision medicine tissue agnostic treatment
  • 3m 2s

    ESR1 Mutation as an emerging clinical biomarker metastatic hormone receptor positive Breast Cancer

    Combination of CDK4/6 inhibitors & aromatase inhibitor is recommended for frontline treatment of Hormone receptor positive (ER+ve) Metastatic Breast Cancer. Patients eventually develop disease progression which might be attributed to ESR1 mutations.
    biomarkers esr1 mutation fulvestrant hormone receptor positive mbc serd
  • Câncer de próstata2m 21s

    Role of Geriatric Assessment in prostate Cancer

    Average at diagnosis of prostate cancer is ~65 years & patients usually have multiple co- morbidities and may be on treatment with multiple prescribed medications.
    geriatric assessment prostate cancer
  • Oncology4m 9s

    Cardio Oncology in Prostate Cancer

    Major cardiovascular toxicities associated with the prostate cancer treatment include arrhythmias, atherosclerosis, myocardial Infarction, hypertension & cardiomyopathy. Toxicities vary with the type of agent used in Prostate Cancer Treatment.
    abcde protocol cardio oncology prostate cancer
  • Oncology2m 8s

    Cardio Oncology & and its integration in Cancer Treatment planning

    Cardiac care is not fully integrated in cancer care plans in most canters across the world. This is an important next step in evolution of cancer care.
    cardiac care cardio oncology safety
  • 3m 36s

    Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

    Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
    tumor-infiltrating lymphocytes (tils) promising biomarker
  • 3m 2s

    ESR1 Mutation as an emerging clinical biomarker metastatic hormone receptor positive Breast Cancer

    Combination of CDK4/6 inhibitors & aromatase inhibitor is recommended for frontline treatment of Hormone receptor positive (ER+ve) Metastatic Breast Cancer. Patients eventually develop disease progression which might be attributed to ESR1 mutations.
    biomarkers esr1 mutation fulvestrant hormone receptor positive mbc serd
  • Últimos vídeos

    Últimos vídeos

    Short Cards Listing
    Hola, ¿puedo ayudar?
    Suporte por bate-papoX
    Equipe de suporte
    Hola, ¿cómo puedo ayudarlo hoy?
    Seleccione una de las siguientes opciones.

    Buscar información

    No puedo iniciar sesión o registrarse

    compartilhar comentarios